Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Homology Medicines, Inc. | Director | Option (Right to Buy) | 18K | $242K | $13.42 | Jun 15, 2022 | Direct |
Rallybio Corp | Director | Option (Right to Buy) | 16.5K | $29.2K | $1.77 | May 15, 2024 | Direct |
Vor Biopharma Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 16.9K | Jun 14, 2022 | Direct | ||
Entrada Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 16K | Jun 13, 2024 | Direct | ||
Akouos, Inc. | Director, 10%+ Owner | Common Stock | 0 | $12.50 | Nov 30, 2022 | Indirect | |
Akouos, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 0 | Dec 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRDA | Entrada Therapeutics, Inc. | Jun 13, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director, 10%+ Owner |
RLYB | Rallybio Corp | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
RLYB | Rallybio Corp | Jan 2, 2024 | 1 | $48K | 4 | Jan 4, 2024 | Director |
TRDA | Entrada Therapeutics, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director, 10%+ Owner |
RLYB | Rallybio Corp | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
RLYB | Rallybio Corp | Mar 7, 2023 | 1 | -$820K | 4 | Mar 9, 2023 | Director |
RLYB | Rallybio Corp | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
AKUS | Akouos, Inc. | Nov 30, 2022 | 3 | $0 | 4 | Dec 2, 2022 | Director, 10%+ Owner |
AKUS | Akouos, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director, 10%+ Owner |
FIXX | Homology Medicines, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
VOR | Vor Biopharma Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director, 10%+ Owner |
RLYB | Rallybio Corp | Jun 3, 2022 | 2 | -$1.88M | 4 | Jun 7, 2022 | Director, 10%+ Owner |
TRDA | Entrada Therapeutics, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director, 10%+ Owner |
RLYB | Rallybio Corp | May 24, 2022 | 1 | $0 | 4 | May 26, 2022 | Director |
RLYB | Rallybio Corp | May 23, 2022 | 2 | -$1.3M | 4 | May 25, 2022 | Director, 10%+ Owner |
RLYB | Rallybio Corp | Feb 8, 2022 | 2 | -$2.74M | 4 | Feb 10, 2022 | Director |
RLYB | Rallybio Corp | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | Director |
VOR | Vor Biopharma Inc. | Nov 16, 2021 | 2 | -$5.06M | 4 | Nov 18, 2021 | Director, 10%+ Owner |
TRDA | Entrada Therapeutics, Inc. | Nov 2, 2021 | 11 | $5M | 4 | Nov 5, 2021 | Director, 10%+ Owner |
TRDA | Entrada Therapeutics, Inc. | Oct 28, 2021 | 0 | $0 | 3/A | Nov 5, 2021 | Director, 10%+ Owner |
TRDA | Entrada Therapeutics, Inc. | Oct 28, 2021 | 1 | $0 | 4 | Nov 1, 2021 | Director, 10%+ Owner |
RLYB | Rallybio Corp | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director, 10%+ Owner |
RLYB | Rallybio Corp | Jul 28, 2021 | 8 | $8M | 4 | Aug 4, 2021 | Director |
AKUS | Akouos, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director, 10%+ Owner |
FIXX | Homology Medicines, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |